News
FDA approves drug for thrombocytopenia in CLD
The US Food and Drug Administration (FDA) has approved avatrombopag (DOPTELET®), a second-generation thrombopoietin receptor agonist....
News
Protein may be therapeutic target for AML
A signaling protein may be a “potent” therapeutic target for acute myeloid leukemia (AML), according to a paper published in the Journal of...
News
Older, cheaper drug formulation to remain available
The 140 mg capsules of Imbruvica® (ibrutinib) will remain on the market, according to Pharmacyclics LLC. Pharmacyclics (an AbbVie company) and...
News
Drug makers may be blocking generic competition
The US Food and Drug Administration (FDA) has released a list of companies that “may be pursuing gaming tactics to delay generic competition.”...
News
Better matching for blood transfusions
Researchers have developed software that could enable more precise matching for blood transfusions, according to a paper published in The Lancet...
News
Bacterial signals set the stage for PMP
Preclinical research suggests bacterial signals are crucial to the development of pre-leukemic myeloproliferation (PMP). Researchers found that...
News
EHRs enhance clinical trial follow-up
Electronic health records (EHRs) can enhance results from randomized controlled trials (RCTs), according to research published in Scientific...
News
Regimen can improve DFS in newly diagnosed T-ALL
The addition of nelarabine can improve treatment outcomes for certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to a...
News
Treating insomnia in cancer survivors
Treatment with acupuncture or cognitive behavioral therapy (CBT) can decrease the severity of insomnia among cancer survivors, according to new...
News
FDA approves first epoetin alfa biosimilar
The US Food and Drug Administration (FDA) has approved epoetin alfa-epbx (Retacrit), a biosimilar to epoetin alfa (Epogen/Procrit). Epoetin alfa-...
News
Team analyzes skin odor to detect malaria
Changes in skin odor can reveal malaria infection in patients with no external symptoms, according to research published in PNAS. Researchers...
News
Umbralisib has ‘distinct’ safety profile
Phase 1 trial results suggest umbralisib, a PI3Kδ/CK1ε inhibitor, can be safe and active in patients with relapsed or refractory B-cell...
News
FDA approves new use for Zika test
The US Food and Drug Administration (FDA) has approved an additional use for the cobas Zika test. The approval allows for the streamlined...
News
Study reveals gender imbalance in cancer research funding
A new study suggests male investigators in the UK receive more funding for cancer research than their female counterparts. Researchers analyzed...
News
NCCN releases guidelines for AML patients
The National Comprehensive Cancer Network (NCCN) has released guidelines for patients with acute myeloid leukemia (AML). The guidelines are...